{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:06:12Z","timestamp":1785769572672,"version":"3.56.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Bodossaki Foundation, Greece"},{"DOI":"10.13039\/501100005302","name":"Onassis Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005302","id-type":"DOI","asserted-by":"crossref"}]},{"name":"State Scholarship Foundation of Greece"},{"name":"Bodossaki Foundation, Greece"},{"DOI":"10.13039\/501100005302","name":"Onassis Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005302","id-type":"DOI","asserted-by":"crossref"}]},{"name":"State Scholarship Foundation of Greece"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.gene.2013.11.085","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T05:32:29Z","timestamp":1386739949000},"page":"65-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human"],"prefix":"10.1016","volume":"536","author":[{"given":"Theodora","family":"Tsirka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiria","family":"Boukouvala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogos","family":"Agianian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giannoulis","family":"Fakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2013.11.085_bb0270","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.gene.2013.11.085_bb0150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/molehr\/5.7.636","article-title":"Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis","volume":"5","author":"Baranova","year":"1999","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.gene.2013.11.085_bb0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00008571-200207000-00006","article-title":"Identification and functional characterization of novel polymorphisms associated with the genes for arylamine N-acetyltransferases in mice","volume":"12","author":"Boukouvala","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.gene.2013.11.085_bb0140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj20030812","article-title":"Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolizing enzyme arylamine N-acetyltransferase type 2 in mice","volume":"375","author":"Boukouvala","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.gene.2013.11.085_bb0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/pr.110.004275","article-title":"Arylamine N-acetyltransferase 1: a novel drug target in cancer development","volume":"64","author":"Butcher","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.gene.2013.11.085_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.toxlet.2005.10.015","article-title":"Genetic basis of toxic reactions to drugs and chemicals","volume":"162","author":"Cascorbi","year":"2006","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.gene.2013.11.085_bb0265","doi-asserted-by":"crossref","unstructured":"Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS ONE 7(10): e46688.","DOI":"10.1371\/journal.pone.0046688"},{"key":"10.1016\/j.gene.2013.11.085_bb0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.tpj.6500170","article-title":"Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene","volume":"3","author":"Cornish","year":"2003","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.gene.2013.11.085_bb0190","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/mol.58.2.288","article-title":"Characterization of naturally occurring and recombinant human N-acetyltransferase variants encoded by NAT1","volume":"58","author":"de Leon","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.gene.2013.11.085_bb0180","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/JB.183.11.3417-3427.2001","article-title":"Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid","volume":"183","author":"Delomenie","year":"2001","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.gene.2013.11.085_bb0260","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1006\/bbrc.1997.6501","article-title":"Identification of a novel allele at the human NAT1 acetyltransferase locus","volume":"233","author":"Doll","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2013.11.085_bb0250","doi-asserted-by":"crossref","first-page":"26830","DOI":"10.1016\/S0021-9258(18)47094-9","article-title":"Structure\u2013function studies of human arylamine N-acetyltransferases NAT1 and NAT2. Functional analysis of recombinant NAT1\/NAT2 chimeras expressed in Escherichia coli","volume":"269","author":"Dupret","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2013.11.085_bb0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbrc.2008.03.085","article-title":"An N-ethyl-N-nitrosourea-induced mutation in N-acetyltransferase 1 in mice","volume":"379","author":"Erickson","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2013.11.085_bb0135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000015648","article-title":"Chromosome mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel upstream noncoding exon for murine Nat2","volume":"90","author":"Fakis","year":"2000","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.gene.2013.11.085_bb0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/FPC.0b013e328011e3ad","article-title":"Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis","volume":"17","author":"Fakis","year":"2007","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.gene.2013.11.085_bb0280","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/10937400701873456","article-title":"Endocrine toxicants including 2,3,7,8-terachlorodibenzo-p-dioxin (TCDD) and dioxin-like chemicals and endometriosis: is there a link?","volume":"11","author":"Foster","year":"2008","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1016\/j.gene.2013.11.085_bb0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00008571-200104000-00004","article-title":"Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms","volume":"11","author":"Fretland","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.gene.2013.11.085_bb0005","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.febslet.2010.05.063","article-title":"Comparative genomic and phylogenetic investigation of the xenobiotic metabolizing arylamine N-acetyltransferase enzyme family","volume":"584","author":"Glenn","year":"2010","journal-title":"FEBS Lett."},{"issue":"Pt 1","key":"10.1016\/j.gene.2013.11.085_bb0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj3480159","article-title":"Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2","volume":"348","author":"Goodfellow","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.gene.2013.11.085_bb0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0026-895X(25)10988-7","article-title":"Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes","volume":"39","author":"Grant","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.gene.2013.11.085_bb0245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0027-5107(97)00026-2","article-title":"Human acetyltransferase polymorphisms","volume":"376","author":"Grant","year":"1997","journal-title":"Mutat. Res."},{"key":"10.1016\/j.gene.2013.11.085_bb0205","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/17425250902877698","article-title":"N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine","volume":"5","author":"Hein","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.gene.2013.11.085_bb0215","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/hmg\/3.5.729","article-title":"Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes","volume":"3","author":"Hein","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.gene.2013.11.085_bb0175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bcp.2004.09.014","article-title":"Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening","volume":"69","author":"Kawamura","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.gene.2013.11.085_bb0165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nprot.2009.182","article-title":"Nonlinear least-squares data fitting in Excel spreadsheets","volume":"5","author":"Kemmer","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.gene.2013.11.085_bb0240","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jmb.2006.06.029","article-title":"Arylamine N-acetyltransferase aggregation and constitutive ubiquitylation","volume":"361","author":"Liu","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.gene.2013.11.085_bb0185","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1021\/tx7001614","article-title":"Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2","volume":"20","author":"Liu","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.gene.2013.11.085_bb0170","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1073\/pnas.1201964109","article-title":"Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197","volume":"109","author":"Malito","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.11.085_bb0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0026-895X(25)12944-1","article-title":"Molecular genetic basis of rapid and slow acetylation in mice","volume":"40","author":"Martell","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.gene.2013.11.085_bb0155","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/molehr\/7.11.1079","article-title":"Association between endometriosis and N-acetyltransferase 2 polymorphism in a UK population","volume":"7","author":"Nakago","year":"2001","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.gene.2013.11.085_bb0050","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/aje\/kwm066","article-title":"A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer","volume":"166","author":"Ochs-Balcom","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.gene.2013.11.085_bb0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1086\/500614","article-title":"Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes","volume":"78","author":"Patin","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2013.11.085_bb0070","doi-asserted-by":"crossref","first-page":"e25801","DOI":"10.1371\/journal.pone.0025801","article-title":"Effects of single nucleotide polymorphisms on human N-acetyltransferase 2 structure and dynamics by molecular dynamics simulation","volume":"6","author":"Rajasekaran","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2013.11.085_bb0275","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.bmc.2008.11.032","article-title":"Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2","volume":"17","author":"Russell","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.gene.2013.11.085_bb0035","doi-asserted-by":"crossref","first-page":"e18507","DOI":"10.1371\/journal.pone.0018507","article-title":"Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey","volume":"6","author":"Sabbagh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2013.11.085_bb0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2148-13-62","article-title":"Rapid birth-and-death evolution of the xenobiotic metabolizing NAT gene family in vertebrates with evidence of adaptive selection","volume":"13","author":"Sabbagh","year":"2013","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.gene.2013.11.085_bb0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/aje\/kwm167","article-title":"Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis","volume":"166","author":"Sanderson","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.gene.2013.11.085_bb0075","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/03602530802186603","article-title":"Arylamine N-acetyltransferases: from structure to function","volume":"40","author":"Sim","year":"2008","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.gene.2013.11.085_bb0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-398339-8.00005-7","article-title":"Arylamine N-acetyltransferases\u2014from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention","volume":"63","author":"Sim","year":"2012","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.gene.2013.11.085_bb0060","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/76783","article-title":"Structure of arylamine N-acetyltransferase reveals a catalytic triad","volume":"7","author":"Sinclair","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.gene.2013.11.085_bb0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/mol.64.1.170","article-title":"Generation and functional characterization of arylamine N-acetyltransferase Nat1\/Nat2 double-knockout mice","volume":"64","author":"Sugamori","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.gene.2013.11.085_bb0110","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1124\/dmd.106.010819","article-title":"In vivo and in vitro metabolism of arylamine procarcinogens in acetyltransferase-deficient mice","volume":"34","author":"Sugamori","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.gene.2013.11.085_bb0105","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1124\/dmd.111.038216","article-title":"Liver-selective expression of human arylamine N-acetyltransferase NAT2 in transgenic mice","volume":"39","author":"Sugamori","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.gene.2013.11.085_bb0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.canlet.2011.12.022","article-title":"Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice","volume":"318","author":"Sugamori","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2013.11.085_bb0045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1590\/S0074-02762011000600011","article-title":"Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients","volume":"106","author":"Teixeira","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.gene.2013.11.085_bb0200","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2174\/138920008785821729","article-title":"Arylamine N-acetyltransferases in prokaryotic and eukaryotic genomes: a survey of public databases","volume":"9","author":"Vagena","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.gene.2013.11.085_bb0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/13547500701673529","article-title":"Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system","volume":"13","author":"Wakefield","year":"2008","journal-title":"Biomarkers"},{"key":"10.1016\/j.gene.2013.11.085_bb0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.gene.2009.12.002","article-title":"Characterisation of CpG methylation in the upstream control region of mouse Nat2: evidence for a gene\u2013environment interaction in a polymorphic gene implicated in folate metabolism","volume":"452","author":"Wakefield","year":"2010","journal-title":"Gene"},{"key":"10.1016\/j.gene.2013.11.085_bb0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/10937400903158383","article-title":"Genetic polymorphism in N-acetyltransferase (NAT): population distribution of NAT1 and NAT2 activity","volume":"12","author":"Walker","year":"2009","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1016\/j.gene.2013.11.085_bb0210","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/138920008784892065","article-title":"Structure\/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2","volume":"9","author":"Walraven","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.gene.2013.11.085_bb0255","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10930-004-1513-9","article-title":"Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1","volume":"24","author":"Wang","year":"2005","journal-title":"Protein J."},{"key":"10.1016\/j.gene.2013.11.085_bb0015","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrd1497","article-title":"Pharmacogenomics: bench to bedside","volume":"3","author":"Weinshilboum","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.gene.2013.11.085_bb0065","doi-asserted-by":"crossref","first-page":"30189","DOI":"10.1074\/jbc.M704138200","article-title":"Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases","volume":"282","author":"Wu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2013.11.085_bb0230","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00008571-200411000-00002","article-title":"The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation","volume":"14","author":"Zang","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.gene.2013.11.085_bb0225","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/carcin\/bgm085","article-title":"Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2","volume":"28","author":"Zang","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.gene.2013.11.085_bb0235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/01.fpc.0000236325.73186.2c","article-title":"Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2","volume":"17","author":"Zang","year":"2007","journal-title":"Pharmacogenet. Genomics"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111913016119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111913016119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T04:07:37Z","timestamp":1746072457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111913016119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0378111913016119"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2013.11.085","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2013.11.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}